Eight out of Ten Photosoft compounds showed antiviral activity against the Dengue virus after exposure to light. The eight compounds have superior Therapeutic Index (TI) values to Monensin. The most effective compound had an EC50 (half maximal effective concentration) value that is >90 times lower than Monensin (control drug). No compound displayed antiviral activity when protected from light. The global Dengue treatment market is estimated to hit US$1.3bn by 2030 (11.2% CAGR)
FULL ARTICLE
